市場調査レポート
商品コード
1309835

ペプチド医薬品市場:タイプ別、用途別、投与経路別、流通チャネル別 - 世界予測、2023年~2032年

Peptide Therapeutics Market - By Type (Branded, Generic), By Application (Metabolic, Cancer, Cardiovascular, Gastrointestinal), By Route of Administration (Parenteral, Oral), By Distribution Channel (Hospital, Retail)- Global Forecast 2023 to 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 240 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ペプチド医薬品市場:タイプ別、用途別、投与経路別、流通チャネル別 - 世界予測、2023年~2032年
出版日: 2023年05月10日
発行: Global Market Insights Inc.
ページ情報: 英文 240 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のペプチド医薬品市場は、2023年から2032年にかけて飛躍的な成長を遂げると思われます。

糖尿病、がん、心血管障害などの慢性疾患の負担増に伴い、個別化された標的治療オプションに対する需要の高まりが、今後10年間の業界の収益源を刺激します。WHOによると、糖尿病は世界で約4億2,200万人が罹患し、毎年150万人の命を奪っています。

ペプチド医薬品は、高い特異性、低毒性、優れた生体適合性などの利点を備えており、医薬品開発にとって魅力的な選択肢となっています。ペプチド合成技術やドラッグデリバリーシステムの進歩により、ペプチド医薬品の安定性、バイオアベイラビリティ、半減期が改善され、その採用がさらに進んでいます。さらに、学術機関と製薬企業との共同研究の増加に伴う研究開発活動の進展が、ペプチドによる新規療法の発見に拍車をかけ、市場の成長を後押ししています。

ペプチド医薬品市場全体のシェアは、タイプ、用途、投与経路、流通チャネル、地域によって分類されます。

タイプ別では、ジェネリックペプチド治療薬業界は 2032年までに大幅な成長を記録すると予想されます。先発のペプチド医薬品の特許が切れたことで、費用対効果の高い代替品を提供するジェネリック医薬品の市場が開かれました。慢性疾患の負担増は、手頃な価格の治療オプションに対するニーズを生み出し、ジェネリックのペプチド医薬品の需要をさらに刺激しています。加えて、ジェネリック医薬品の使用を促進する規制当局の取り組みが、世界中の医療システムにおけるジェネリック医薬品の採用を後押ししており、これが今後数年間の同分野の利益を拡大する一助となると思われます。

用途別では、がんセグメントのペプチド医薬品の市場規模が2023~2032年にかけて大きく成長します。がん用途におけるペプチド医薬品の需要は、標的治療や個別化治療の可能性から増加しています。ペプチドは、健康な細胞を温存しながらがん細胞を特異的に標的とすることができるため、副作用が軽減されます。さらに、免疫チェックポイント阻害剤のようなペプチドによる免疫療法は、がん細胞に対する身体の免疫反応を高めるという有望な結果を示しています。

投与経路に基づくと、経口投与セグメントは2032年までにペプチド医薬品業界の収益で注目すべきシェアを獲得する可能性があります。経口投与は非侵襲的であり、患者にとってより便利であるため、コンプライアンスと治療継続性が向上します。ペプチド安定剤や酵素阻害剤の使用など製剤技術の進歩により、ペプチド医薬品の経口バイオアベイラビリティと安定性が向上しています。これとは別に、経口投与は、注射や点滴といった他の経路に比べてコスト削減の可能性があり、さらにこのセグメントの利益に貢献しています。

地域別では、アジア太平洋地域のペプチド医薬品市場が2023年から2032年にかけて高い成長率を示すと思われます。がん、糖尿病、心血管障害などの慢性疾患の増加により、効果的な治療法に対するニーズが高まっています。医療支出の増加、中間所得層の拡大、医療インフラの改善が、需要の増加にさらに寄与しています。加えて、中国、日本、韓国などの国々における研究開発能力の進歩が技術革新を促進し、ペプチドによる治療法の開発がこの地域の市場成長を牽引しています。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 ペプチド医薬品市場の洞察

  • 業界情勢、2018年~2032年
  • 業界への影響要因
    • 促進要因
      • がんの有病率の増加
      • 代謝性疾患の増加
      • 新薬の研究開発投資の増加
      • ペプチド医薬品の技術進歩
    • 業界の潜在的リスク&課題
      • 医薬品承認のための厳しい規制要件
      • 医薬品開発コストの高さ
  • 成長可能性分析
    • タイプ別
    • 用途別
    • 投与経路別
    • メーカータイプ別
    • 合成技術別
    • 販売チャネル別
  • COVID-19の影響分析
  • 規制状況
  • ポーター分析
  • PESTEL分析

第4章 競合情勢、2022年

  • イントロダクション
  • 企業マトリックス分析、2022年
  • 世界企業の市場シェア分析、2022年
  • 競合のポジショニングマトリックス、2022年
  • 戦略ダッシュボード、2022年

第5章 ペプチド医薬品市場推計・予測:タイプ別

  • 主要動向:タイプ別
  • ブランド
  • ジェネリック

第6章 ペプチド医薬品市場推計・予測:用途別

  • 主要動向:用途別
  • 代謝疾患
  • がん
  • 心血管疾患
  • 消化器疾患
  • 中枢神経系疾患
  • 感染症
  • 呼吸器疾患
  • 疼痛管理
  • 腎臓疾患
  • 皮膚科学
  • その他の用途

第7章 ペプチド医薬品市場推定・予測:投与経路別

  • 主要動向:投与経路別
  • 非経口
  • 経口
  • その他の投与経路

第8章 ペプチド医薬品の市場推計・予測:メーカータイプ別

  • 主要動向:メーカータイプ別
  • 自社
  • アウトソーシング

第9章 ペプチド医薬品市場推計・予測:合成技術別

  • 主要動向:合成技術別
  • 液相ペプチド合成(LPPS)
  • 固相ペプチド合成(SPPS)
  • ハイブリッド技術

第10章 ペプチド医薬品市場推計・予測:流通チャネル別

  • 主要動向:流通チャネル別
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第11章 ペプチド医薬品市場推定・予測:地域別

  • 主要動向:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • スイス
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • その他の中東・アフリカ

第12章 企業プロファイル

  • Pfizer, Inc
  • Amgen, Inc
  • Bachem Holding AG
  • Eli Lilly and Company
  • Sanofi
  • AstraZeneca plc
  • AbbVie
  • GlaxoSmithKline plc
  • Baush Health
  • Lonza Inc.
図表

Data Tables

  • TABLE 1 Product mapping
  • TABLE 2 Market revenue, by type (2022)
  • TABLE 3 Market revenue, by application (2022)
  • TABLE 4 Market revenue, by route of administration (2022)
  • TABLE 5 Market revenue, by manufacturer type (2022)
  • TABLE 6 Market revenue, by synthesis technology (2022)
  • TABLE 7 Market share, by distribution channel (2022)
  • TABLE 8 Market share, by region (2022)
  • TABLE 9 Global peptide therapeutics market size, by region, 2018 - 2022 (USD Billion)
  • TABLE 10 Global peptide therapeutics market size, by region, 2023 - 2032 (USD Billion)
  • TABLE 11 Global peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 12 Global peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 13 Global peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 14 Global peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 15 Global peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 16 Global peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 17 Global peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 18 Global peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 19 Global peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 20 Global peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 21 Global peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 22 Global peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 23 Industry impact forces
  • TABLE 24 Competitive benchmarking of major market players
  • TABLE 25 Competitive positioning matrix: Classification criteria
  • TABLE 26 Strategic outlook matrix: Classification criteria
  • TABLE 27 Branded peptides market size, 2018 - 2022 (USD Billion)
  • TABLE 28 Branded peptides market size, 2023 - 2032 (USD Billion)
  • TABLE 29 Generic peptides market size, 2018 - 2022 (USD Billion)
  • TABLE 30 Generic peptides market size, 2023 - 2032 (USD Billion)
  • TABLE 31 Metabolic disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 32 Metabolic disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 33 Cancer market size, 2018 - 2022 (USD Billion)
  • TABLE 34 Cancer market size, 2023 - 2032 (USD Billion)
  • TABLE 35 Cardiovascular disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 36 Cardiovascular disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 37 Gastrointestinal disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 38 Gastrointestinal disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 39 Central nervous system disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 40 Central nervous system disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 41 Infectious diseases market size, 2018 - 2022 (USD Billion)
  • TABLE 42 Infectious diseases market size, 2023 - 2032 (USD Billion)
  • TABLE 43 Respiratory disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 44 Respiratory disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 45 Pain management market size, 2018 - 2022 (USD Billion)
  • TABLE 46 Pain management market size, 2023 - 2032 (USD Billion)
  • TABLE 47 Renal disorders market size, 2018 - 2022 (USD Billion)
  • TABLE 48 Renal disorders market size, 2023 - 2032 (USD Billion)
  • TABLE 49 Dermatology market size, 2018 - 2022 (USD Billion)
  • TABLE 50 Dermatology market size, 2023 - 2032 (USD Billion)
  • TABLE 51 Other applications market size, 2018 - 2022 (USD Billion)
  • TABLE 52 Other applications market size, 2023 - 2032 (USD Billion)
  • TABLE 53 Parenteral market size, 2018 - 2022 (USD Billion)
  • TABLE 54 Parenteral market size, 2023 - 2032 (USD Billion)
  • TABLE 55 Oral market size, 2018 - 2022 (USD Billion)
  • TABLE 56 Oral market size, 2023 - 2032 (USD Billion)
  • TABLE 57 Other routes of administration market size, 2018 - 2022 (USD Billion)
  • TABLE 58 Other routes of administration market size, 2023 - 2032 (USD Billion)
  • TABLE 59 In-house market size, 2018 - 2022 (USD Billion)
  • TABLE 60 In-house market size, 2023 - 2032 (USD Billion)
  • TABLE 61 Outsourced market size, 2018 - 2022 (USD Billion)
  • TABLE 62 Outsourced market size, 2023 - 2032 (USD Billion)
  • TABLE 63 Liquid phase peptide synthesis market size, 2018 - 2022 (USD Billion)
  • TABLE 64 Liquid phase peptide synthesis market size, 2023 - 2032 (USD Billion)
  • TABLE 65 Solid phase peptide synthesis market size, 2018 - 2022 (USD Billion)
  • TABLE 66 Solid phase peptide synthesis market size, 2023 - 2032 (USD Billion)
  • TABLE 67 Hybrid technology market size, 2018 - 2022 (USD Billion)
  • TABLE 68 Hybrid technology market size, 2023 - 2032 (USD Billion)
  • TABLE 69 North America peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 70 North America peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 71 North America peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 72 North America peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 73 North America peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 74 North America peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 75 North America peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 76 North America peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 77 North America peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 78 North America peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 79 North America peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 80 North America peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 81 North America peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 82 North America peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 83 U.S. peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 84 U.S. peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 85 U.S. peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 86 U.S. peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 87 U.S. peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 88 U.S. peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 89 U.S. peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 90 U.S. peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 91 U.S. peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 92 U.S. peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 93 U.S. peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 94 U.S. peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 95 Canada peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 96 Canada peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 97 Canada peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 98 Canada peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 99 Canada peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 100 Canada peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 101 Canada peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 102 Canada peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 103 Canada peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 104 Canada peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 105 Canada peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 106 Canada peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 107 Europe peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 108 Europe peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 109 Europe peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 110 Europe peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 111 Europe peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 112 Europe peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 113 Europe peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 114 Europe peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 115 Europe peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 116 Europe peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 117 Europe peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 118 Europe peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 119 Europe peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 120 Europe peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 121 Germany peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 122 Germany peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 123 Germany peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 124 Germany peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 125 Germany peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 126 Germany peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 127 Germany peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 128 Germany peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 129 Germany peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 130 Germany peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 131 Germany peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 132 Germany peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 133 UK peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 134 UK peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 135 UK peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 136 UK peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 137 UK peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 138 UK peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 139 UK peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 140 UK peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 141 UK peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 142 UK peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 143 UK peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 144 UK peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 145 France peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 146 France peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 147 France peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 148 France peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 149 France peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 150 France peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 151 France peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 152 France peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 153 France peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 154 France peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 155 France peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 156 France peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 157 Spain peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 158 Spain peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 159 Spain peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 160 Spain peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 161 Spain peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 162 Spain peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 163 Spain peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 164 Spain peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 165 Spain peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 166 Spain peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 167 Spain peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 168 Spain peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 169 Italy peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 170 Italy peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 171 Italy peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 172 Italy peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 173 Italy peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 174 Italy peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 175 Italy peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 176 Italy peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 177 Italy peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 178 Italy peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 179 Italy peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 180 Italy peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 181 Switzerland peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 182 Switzerland peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 183 Switzerland peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 184 Switzerland peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 185 Switzerland peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 186 Switzerland peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 187 Switzerland peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 188 Switzerland peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 189 Switzerland peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 190 Switzerland peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 191 Switzerland peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 192 Switzerland peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 193 Rest of Europe peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 194 Rest of Europe peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 195 Rest of Europe peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 196 Rest of Europe peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 197 Rest of Europe peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 198 Rest of Europe peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 199 Rest of Europe peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 200 Rest of Europe peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 201 Rest of Europe peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 202 Rest of Europe peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 203 Rest of Europe peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 204 Rest of Europe peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 205 Asia Pacific peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 206 Asia Pacific peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 207 Asia Pacific peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 208 Asia Pacific peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 209 Asia Pacific peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 210 Asia Pacific peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 211 Asia Pacific peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 212 Asia Pacific peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 213 Asia Pacific peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 214 Asia Pacific peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 215 Asia Pacific peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 216 Asia Pacific peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 217 Asia Pacific peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 218 Asia Pacific peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 219 China peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 220 China peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 221 China peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 222 China peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 223 China peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 224 China peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 225 China peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 226 China peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 227 China peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 228 China peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 229 China peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 230 China peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 231 Japan peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 232 Japan peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 233 Japan peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 234 Japan peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 235 Japan peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 236 Japan peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 237 Japan peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 238 Japan peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 239 Japan peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 240 Japan peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 241 Japan peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 242 Japan peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 243 India peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 244 India peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 245 India peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 246 India peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 247 India peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 248 India peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 249 India peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 250 India peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 251 India peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 252 India peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 253 India peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 254 India peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 255 Australia peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 256 Australia peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 257 Australia peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 258 Australia peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 259 Australia peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 260 Australia peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 261 Australia peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 262 Australia peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 263 Australia peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 264 Australia peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 265 Australia peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 266 Australia peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 267 South Korea peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 268 South Korea peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 269 South Korea peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 270 South Korea peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 271 South Korea peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 272 South Korea peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 273 South Korea peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 274 South Korea peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 275 South Korea peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 276 South Korea peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 277 South Korea peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 278 South Korea peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 279 Rest of Asia Pacific peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 280 Rest of Asia Pacific peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 281 Rest of Asia Pacific peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 282 Rest of Asia Pacific peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 283 Rest of Asia Pacific peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 284 Rest of Asia Pacific peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 285 Rest of Asia Pacific peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 286 Rest of Asia Pacific peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 287 Rest of Asia Pacific peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 288 Rest of Asia Pacific peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 289 Rest of Asia Pacific peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 290 Rest of Asia Pacific peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 291 Latin America peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 292 Latin America peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 293 Latin America peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 294 Latin America peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 295 Latin America peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 296 Latin America peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 297 Latin America peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 298 Latin America peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 299 Latin America peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 300 Latin America peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 301 Latin America peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 302 Latin America peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 303 Latin America peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 304 Latin America peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 305 Brazil peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 306 Brazil peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 307 Brazil peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 308 Brazil peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 309 Brazil peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 310 Brazil peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 311 Brazil peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 312 Brazil peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 313 Brazil peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 314 Brazil peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 315 Brazil peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 316 Brazil peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 317 Mexico peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 318 Mexico peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 319 Mexico peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 320 Mexico peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 321 Mexico peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 322 Mexico peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 323 Mexico peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 324 Mexico peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 325 Mexico peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 326 Mexico peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 327 Mexico peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 328 Mexico peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 329 Rest of Latin America peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 330 Rest of Latin America peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 331 Rest of Latin America peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 332 Rest of Latin America peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 333 Rest of Latin America peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 334 Rest of Latin America peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 335 Rest of Latin America peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 336 Rest of Latin America peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 337 Rest of Latin America peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 338 Rest of Latin America peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 339 Rest of Latin America peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 340 Rest of Latin America peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 341 MEA peptide therapeutics market size, by country, 2018 - 2022 (USD Billion)
  • TABLE 342 MEA peptide therapeutics market size, by country, 2023 - 2032 (USD Billion)
  • TABLE 343 MEA peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 344 MEA peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 345 MEA peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 346 MEA peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 347 MEA peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 348 MEA peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 349 MEA peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 350 MEA peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 351 MEA peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 352 MEA peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 353 MEA peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 354 MEA peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 355 South Africa peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 356 South Africa peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 357 South Africa peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 358 South Africa peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 359 South Africa peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 360 South Africa peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 361 South Africa peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 362 South Africa peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 363 South Africa peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 364 South Africa peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 365 South Africa peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 366 South Africa peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 367 Saudi Arabia peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 368 Saudi Arabia peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 369 Saudi Arabia peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 370 Saudi Arabia peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 371 Saudi Arabia peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 372 Saudi Arabia peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 373 Saudi Arabia peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 374 Saudi Arabia peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 375 Saudi Arabia peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 376 Saudi Arabia peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 377 Saudi Arabia peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 378 Saudi Arabia peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)
  • TABLE 379 Rest of MEA peptide therapeutics market size, by type, 2018 - 2022 (USD Billion)
  • TABLE 380 Rest of MEA peptide therapeutics market size, by type, 2023 - 2032 (USD Billion)
  • TABLE 381 Rest of MEA peptide therapeutics market size, by application, 2018 - 2022 (USD Billion)
  • TABLE 382 Rest of MEA peptide therapeutics market size, by application, 2023 - 2032 (USD Billion)
  • TABLE 383 Rest of MEA peptide therapeutics market size, by route of administration, 2018 - 2022 (USD Billion)
  • TABLE 384 Rest of MEA peptide therapeutics market size, by route of administration, 2023 - 2032 (USD Billion)
  • TABLE 385 Rest of MEA peptide therapeutics market size, by manufacturer type, 2018 - 2022 (USD Billion)
  • TABLE 386 Rest of MEA peptide therapeutics market size, by manufacturer type, 2023 - 2032 (USD Billion)
  • TABLE 387 Rest of MEA peptide therapeutics market size, by synthesis technology, 2018 - 2022 (USD Billion)
  • TABLE 388 Rest of MEA peptide therapeutics market size, by synthesis technology, 2023 - 2032 (USD Billion)
  • TABLE 389 Rest of MEA peptide therapeutics market size, by distribution channel, 2018 - 2022 (USD Billion)
  • TABLE 390 Rest of MEA peptide therapeutics market size, by distribution channel, 2023 - 2032 (USD Billion)

Charts & Figures

  • FIG 1 GMI report coverage: Critical research elements
  • FIG 2 Top-down approach
  • FIG 3 Market estimation and forecast methodology
  • FIG 4 Market forecasting methodology
  • FIG 5 Breakdown of primary participants
  • FIG 6 Peptide therapeutics industry 360 degree synopsis, 2018 - 2032
  • FIG 7 Growth potential analysis, by type
  • FIG 8 Growth potential analysis, by application
  • FIG 9 Growth potential analysis, by route of administration
  • FIG 10 Growth potential analysis, by manufacturer type
  • FIG 11 Growth potential analysis, by synthesis technology
  • FIG 12 Growth potential analysis, by distribution channel
  • FIG 13 Porter's analysis
  • FIG 14 PESTEL analysis
  • FIG 15 Company matrix analysis, 2022
  • FIG 16 Global Company market share analysis, 2022
  • FIG 17 Competitive positioning matrix, 2022
  • FIG 18 Strategic dashboard, 2022
目次
Product Code: 5635

Global Peptide Therapeutics Market will exhibit exponential growth over 2023- 2032.

Increasing demand for personalized and targeted treatment options pushed by the growing burden of chronic diseases such as diabetes, cancer, and cardiovascular disorders will stimulate industry revenue streams over the next ten years. According to WHO, diabetes affects around 422 million people worldwide and claims the lives of 1.5 million people each year.

Peptide therapeutics offer advantages like high specificity, low toxicity, and excellent biocompatibility, making them an attractive choice for drug development. Advancements in peptide synthesis technologies and drug delivery systems have improved the stability, bioavailability, and half-life of peptide drugs, further propelling their adoption. Moreover, ongoing R&D activities, in line with increasing collaborations between academic institutions and pharmaceutical companies, will fuel the discovery of novel peptide-based therapies, driving market growth.

The overall peptide therapeutics market share is categorized based on type, application, route of administration, distribution channel, and region.

Regarding the type, the generic peptide therapeutics industry will register significant gains through 2032. The expiration of patents for original peptide drugs has opened the market for generic versions, offering cost-effective alternatives. The increasing burden of chronic diseases has created a need for affordable treatment options, further stimulating the demand for generic peptide therapeutics. Besides, regulatory initiatives promoting the use of generic drugs have encouraged their adoption in healthcare systems worldwide, which will help augment segment gains over the coming years.

With respect to application, the peptide therapeutics market size from the cancer segment will grow substantially over 2023-2032. The demand for peptide therapeutics in cancer applications is increasing due to their potential for targeted and personalized treatment. Peptides can specifically target cancer cells while sparing healthy cells, reducing side effects. Additionally, peptide-based immunotherapies, such as immune checkpoint inhibitors, have shown promising results in boosting the body's immune response against cancer cells.

Based on the route of administration, the oral segment could amass a notable share of the peptide therapeutics industry revenue by 2032. Oral delivery is non-invasive and more convenient for patients, improving compliance and treatment adherence. Advances in formulation technologies, such as the use of peptide stabilizers and enzyme inhibitors, have improved the oral bioavailability and stability of peptide drugs. This apart, oral delivery offers potential cost savings compared to other routes, such as injections or infusions, further contributing to segment gains.

Regionally, the Asia Pacific peptide therapeutics market will exhibit an appreciable growth rate between 2023 and 2032. The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disorders, has created a significant need for effective treatment options. Rising healthcare expenditures, expanding middle-class population, and improving healthcare infrastructure have further contributed to the increasing demand. Besides, advancements in R&D capabilities in countries like China, Japan, and South Korea have fostered innovation, and the development of peptide-based therapies will drive market growth in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and calculations
  • 1.3 Forecast calculations
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Public sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Peptide therapeutics industry 360 degree synopsis, 2018 - 2032 (USD Billion)
    • 2.1.1 Business trends
    • 2.1.2 Type trends
    • 2.1.3 Application trends
    • 2.1.4 Route of administration trends
    • 2.1.5 Manufacturer type trends
    • 2.1.6 Synthesis technology trends
    • 2.1.7 Distribution channel trends
    • 2.1.8 Region trends

Chapter 3 Peptide Therapeutics Market Insights

  • 3.1 Industry landscape, 2018 - 2032 (USD Billion)
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of cancer
      • 3.2.1.2 Rising incidences of metabolic disorders
      • 3.2.1.3 Increasing investments in R&D of novel drugs
      • 3.2.1.4 Technological advancement in peptide therapeutics
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory requirements for drug approval
      • 3.2.2.2 High cost for drug development
  • 3.3 Growth potential analysis
    • 3.3.1 By type
    • 3.3.2 By application
    • 3.3.3 By route of administration
    • 3.3.4 By manufacturer type
    • 3.3.5 By synthesis technology
    • 3.3.6 By distribution channel
  • 3.4 COVID-19 impact analysis
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2022
  • 4.3 Global Company market share analysis, 2022
  • 4.4 Competitive positioning matrix, 2022
  • 4.5 Strategic dashboard, 2022

Chapter 5 Peptide Therapeutics Market Estimates and Forecast, By Type (USD Billion)

  • 5.1 Key trends, by type
  • 5.2 Branded peptides
  • 5.3 Generic peptides

Chapter 6 Peptide Therapeutics Market Estimates and Forecast, By Application (USD Billion)

  • 6.1 Key trends, by application
  • 6.2 Metabolic disorders
  • 6.3 Cancer
  • 6.4 Cardiovascular disorders
  • 6.5 Gastrointestinal disorders
  • 6.6 Central nervous system disorders
  • 6.7 Infectious diseases
  • 6.8 Respiratory disorders
  • 6.9 Pain management
  • 6.10 Renal disorders
  • 6.11 Dermatology
  • 6.12 Other applications

Chapter 7 Peptide Therapeutics Market Estimates and Forecast, By Route of Administration (USD Billion)

  • 7.1 Key trends, by route of administration
  • 7.2 Parenteral
  • 7.3 Oral
  • 7.4 Other routes of administration

Chapter 8 Peptide Therapeutics Market Estimates and Forecast, By Manufacturer Type (USD Billion)

  • 8.1 Key trends, by manufacturer type
  • 8.2 In-house
  • 8.3 Outsourced

Chapter 9 Peptide Therapeutics Market Estimates and Forecast, By Synthesis Technology (USD Billion)

  • 9.1 Key trends, by synthesis technology
  • 9.2 Liquid phase peptide synthesis (LPPS)
  • 9.3 Solid phase peptide synthesis (SPPS)
  • 9.4 Hybrid Technology

Chapter 10 Peptide Therapeutics Market Estimates and Forecast, By Distribution Channel (USD Billion)

  • 10.1 Key trends, by distribution channel
  • 10.2 Hospital pharmacies
  • 10.3 Retail pharmacies
  • 10.4 Online pharmacies

Chapter 11 Peptide Therapeutics Market Estimates and Forecast, By Region (USD Billion)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Switzerland
    • 11.3.7 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 South Korea
    • 11.4.6 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East & Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of MEA

Chapter 12 Company Profiles

  • 12.1 Pfizer, Inc
  • 12.2 Amgen, Inc
  • 12.3 Bachem Holding AG
  • 12.4 Eli Lilly and Company
  • 12.5 Sanofi
  • 12.6 AstraZeneca plc
  • 12.7 AbbVie
  • 12.8 GlaxoSmithKline plc
  • 12.9 Baush Health
  • 12.10 Lonza Inc.